keyword
https://read.qxmd.com/read/38697342/expectant-management-of-preeclampsia-with-severe-features-diagnosed-at-less-than-24-weeks
#41
JOURNAL ARTICLE
Kristen A Cagino, Rylee D Trotter, Katherine E Lambert, Saloni C Kumar, Baha M Sibai
BACKGROUND: The recent ACOG practice bulletin offers no guidance on management of preeclampsia with severe features (PreE with SF) less than 24 weeks. Historically, immediate delivery was recommended due to poor perinatal outcomes and high maternal morbidity. Recently, advances in neonatal resuscitation have led to increased survival at peri-viable gestational ages. STUDY DESIGN: We aimed to report perinatal and maternal outcomes after expectant management of PreE with SF at < 24 weeks...
April 30, 2024: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/38695227/contrast-enhanced-ultrasound-as-a-diagnostic-procedure-in-renal-diseases-a-case-report
#42
JOURNAL ARTICLE
Simone Sellitto, Luciano Tarantino, Francesco Barone, Nunzia Barone, Angelica Perna, Angela Lucariello, Germano Guerra, Antonio De Luca, Amelia Filippelli, Carmine Sellitto
Standard ultrasound (US) finds wide use in renal diseases as a screening procedure, but it is not always able to characterize lesions, especially in differential diagnosis between benign and malignant lesions. In contrast, contrast-enhanced ultrasonography (CEUS) is appropriate in differentiating between solid and cystic lesions as well as between tumors and pseudotumors. We show the case of a nephropathic patient who showed a complex, large, growing renal mass, characterized through a CEUS. This seventy-five-year-old diabetic heart patient showed a 6 cm-complex and plurisected cyst on ultrasound of left kidney...
April 29, 2024: Giornale Italiano di Nefrologia: Organo Ufficiale Della Società Italiana di Nefrologia
https://read.qxmd.com/read/38694929/vitamin-d-deficiency-in-patients-hospitalized-for-heart-failure-living-in-the-tropics
#43
JOURNAL ARTICLE
Lucian Batista de Oliveira, Mariana Andrade de Figueiredo Martins Siqueira, Rafael Buarque de Macedo Gadêlha, Jessica Garcia, Francisco Bandeira
BACKGROUND AND OBJECTIVES: Vitamin D, as a steroid hormone, has multiple effects on human body and its deficiency has been associated with an increased risk of heart failure (HF) and unfavorable outcomes. The present study investigated the prevalence of vitamin D deficiency (VDD) and its relationship with cardiometabolic parameters in patients hospitalized for HF living in the city of Recife (latitude 8° South). METHODS: Analytical cross-sectional study, with men and women aged 40-64 years...
April 2024: International journal of heart failure
https://read.qxmd.com/read/38694909/sotagliflozin-versus-dapagliflozin-to-improve-outcome-of-patients-with-diabetes-and-worsening-heart-failure-a-cost-per-outcome-analysis
#44
JOURNAL ARTICLE
Weichen Zhang, Meichen Yu, Guohua Cheng
BACKGROUND AND AIM: Dapagliflozin inhibits the sodium-glucose cotransporter protein 2 (SGLT-2), while sotagliflozin, belonging to a new class of dual-acting SGLT-1/SGLT-2 inhibitors, has garnered considerable attention due to its efficacy and safety. Both Dapagliflozin and sotagliflozin play a significant role in treating worsening heart failure in diabetes/nondiabetes patients with heart failure. Therefore, this article was to analyze and compare the cost per outcome of both drugs in preventing one event in patients diagnosed with diabetes-related heart failure...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38694637/prevalence-and-risk-factors-of-cardiovascular-disease-in-chronic-kidney-disease-patients-at-king-abdulaziz-university-hospital-kauh
#45
JOURNAL ARTICLE
Rana A Nabalawi, Mohammed Abdullah Bamuflih, Abdullah Alaa Farid, Khalid Ghali Almramhi, Muhannad Salem Dawood, Mohammad Salah Ahmed, Khaled S Alfawaz, Abdulaziz Mustafa Adnan
BACKGROUND: Chronic kidney disease (CKD) has emerged as a significant global health concern, with its incidence doubling over the past three decades. Cardiovascular diseases (CVD) pose a major threat to CKD patients, surpassing the risk of progressing to end-stage renal disease. While previous studies worldwide have shed light on this association, limited research has been conducted in Saudi Arabia regarding this burden. This study aims to fill this gap by identifying the prevalence and risk factors of CVD in CKD patients at King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia, between 2017 and 2022...
April 2024: Curēus
https://read.qxmd.com/read/38694375/teucrium-polium-new-toxic-effects-added-to-the-literature-a-case-report
#46
Ali Ghassa, Mousa Ismail, Leen Alabd Alrazak Alani
INTRODUCTION AND IMPORTANCE: Teucrium polium is one of the aromatic plants that grows in the Mediterranean region, and had been used as an herbal treatment for diabetes due to its hypoglycaemia effect. Although this plant is being studied now for its therapeutic role, its side effects are not taken enough into consideration, so this unique case can shed the light on serious toxic effects of this plant. CASE PRESENTATION: A 68-year-old woman presented to the hospital with generalized fatigue, malaise, nausea, vomiting, abdominal pain, polydipsia, polyuria, breathlessness, and no defecation for 2 days after drinking big amounts of teucrium polium...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38694062/lipid-profile-inflammatory-biomarkers-endothelial-dysfunction-and-heart-rate-variability-in-adolescents-with-type-1-diabetes-a-case-control-study-among-uae-population
#47
JOURNAL ARTICLE
Charu Sharma, Abubaker Suliman, Sania Al Hamed, Javed Yasin, Juma AlKaabi, Elhadi Husein Aburawi
BACKGROUND: Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the chronic inflammation and cause of endothelial dysfunction (ED). Heart rate variability (HRV) is a marker of sympathetic and parasympathetic autonomic nervous system dysfunction. We investigated the association of lipid profile, inflammatory biomarkers, endothelial dysfunction, and heart rate variability in adolescents with T1DM among UAE population. METHOD: In this case-control study we recruited 126 adolescents (13-22 years) from Abu Dhabi, UAE (United Arab Emirates)...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38693556/prevalence-of-metabolic-syndrome-among-patients-with-hepatocellular-carcinoma-of-different-etiologies-a-retrospective-study
#48
JOURNAL ARTICLE
Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li, Jian-Hong Zhong
AIMS: This study compared the prevalences of metabolic syndrome and of cardiac or kidney comorbidities among patients with hepatocellular carcinoma (HCC) associated with metabolic dysfunction-related fatty liver disease (MAFLD), chronic infection with hepatitis B or C virus (HBV or HCV), or the combination of MAFLD and chronic HBV infection. METHODS: Medical records were retrospectively analyzed for patients with HCC who underwent hepatectomy between March 2013 and March 2023...
May 1, 2024: Infectious Agents and Cancer
https://read.qxmd.com/read/38693484/obesity-and-metabolic-syndrome-in-patients-with-heart-failure-with-preserved-ejection-fraction-a-cross-sectional-analysis-of-the-veradigm-cardiology-registry
#49
JOURNAL ARTICLE
Jay P Bae, Lee Kallenbach, David R Nelson, Kevin Lavelle, Jessamine P Winer-Jones, Machaon Bonafede, Masahiro Murakami
BACKGROUND: The proportion of heart failure patients with preserved ejection fraction has been rising over the past decades and has coincided with increases in the prevalence of obesity and metabolic syndrome. The relationship between these interconnected comorbidities and heart failure with preserved ejection fraction (HFpEF) is still poorly understood. This study characterized obesity and metabolic syndrome among real-world patients with HFpEF. METHODS: We identified adults with heart failure in the Veradigm Cardiology Registry, previously the PINNACLE Registry, with a left ventricular ejection fraction measurement ≥ 50% between 01/01/2016 and 12/31/2019...
May 1, 2024: BMC Endocrine Disorders
https://read.qxmd.com/read/38693141/the-role-of-ifi16-in-regulating-panoptosis-and-implication-in-heart-diseases
#50
REVIEW
Xindi Chang, Bei Wang, Yingli Zhao, Bing Deng, Ping Liu, Yiru Wang
Interferon Gamma Inducible Protein 16 (IFI16) belongs to the HIN-200 protein family and is pivotal in immunological responses. Serving as a DNA sensor, IFI16 identifies viral and aberrant DNA, triggering immune and inflammatory responses. It is implicated in diverse cellular death mechanisms, such as pyroptosis, apoptosis, and necroptosis. Notably, these processes are integral to the emergent concept of PANoptosis, which encompasses cellular demise and inflammatory pathways. Current research implies a significant regulatory role for IFI16 in PANoptosis, particularly regarding cardiac pathologies...
May 1, 2024: Cell Death Discovery
https://read.qxmd.com/read/38692717/cost-analysis-for-initiating-an-integrated-package-of-essential-non-communicable-disease-interventions-pen-plus-in-kondoa-district-hospital-tanzania-a-time-driven-activity-based-costing-tdabc-study-protocol
#51
JOURNAL ARTICLE
Harrieth Peter Ndumwa, Amani Thomas Mori, George Mugambage Ruhago, Ritha Willilo, Ryan McBain, Chantelle Boudreaux, Emily Wroe, Alma J Adler, Gene Bukhman, Mary Theodory Mayige, Oddvar Kaarboe
INTRODUCTION: Non-communicable diseases (NCDs) constitute approximately 74% of global mortality, with 77% of these deaths occurring in low-income and middle-income countries. Tanzania exemplifies this situation, as the percentage of total disability-adjusted life years attributed to NCDs has doubled over the past 30 years, from 18% to 36%. To mitigate the escalating burden of severe NCDs, the Tanzanian government, in collaboration with local and international partners, seeks to extend the integrated package of essential interventions for severe NCDs (PEN-Plus) to district-level facilities, thereby improving accessibility...
May 1, 2024: BMJ Open
https://read.qxmd.com/read/38690659/ertugliflozin-for-functional-mitral-regurgitation-associated-with-heart-failure-effort-trial
#52
JOURNAL ARTICLE
Duk-Hyun Kang, Sung-Ji Park, Sung-Hee Shin, In-Chang Hwang, Yeonyee Elizabeth Yoon, Hyung-Kwan Kim, Mijin Kim, Min-Seok Kim, Sung-Cheol Yun, Jong-Min Song, Seok-Min Kang
BACKGROUND: The morbidity and mortality rates of patients with heart failure (HF) and functional mitral regurgitation (MR) remain substantial despite guideline-directed medical therapy for HF. We evaluated the efficacy of ertugliflozin for reduction of functional MR associated with HF with mild to moderately reduced ejection fraction. METHODS: The EFFORT trial (Ertugliflozin for Functional Mitral Regurgitation) was a multicenter, double-blind, randomized trial to examine the hypothesis that the sodium-glucose cotransporter 2 inhibitor ertugliflozin is effective for improving MR in patients with HF with New York Heart Association functional class II or III, 35%≤ejection fraction<50%, and effective regurgitant orifice area of chronic functional MR >0...
May 1, 2024: Circulation
https://read.qxmd.com/read/38690477/the-prevalence-and-predictors-of-atherosclerotic-coronary-artery-disease-in-rheumatic-and-non-rheumatic-valvular-heart-disease-patients
#53
JOURNAL ARTICLE
Shahida Shafi, Sihem Aouabdi, Ziad A Taher, Abdulrahman E Alghamdi, Mohammed A Ahmed, Fatima A Ahmed, Suliman Alghamdi, Ali Haneef
OBJECTIVES: The paradox of concurrent coronary artery disease (CAD) among patients with rheumatic and non-rheumatic valvular heart disease (RVHD; non-RVHD) is unclear. We aimed to evaluate the impact of the RVHD and non-RVHD on the prevalence of CAD and various risk factors, assess the number of diseased coronaries, clinical profile and the possible predictors of CAD in these patients, which may clarify the paradox and provide an insight for the prevention of CAD. METHODS: The records of 106 valvular heart disease patients who had undergone valve replacement surgery at the King Faisal Cardiac Centre from January 2014 to October 2019 were evaluated...
March 2024: Curēus
https://read.qxmd.com/read/38689889/the-prognostic-value-of-serum-%C3%AE-klotho-in-age-related-diseases-among-the-us-population-a-prospective-population-based-cohort-study
#54
JOURNAL ARTICLE
Zhiwen Yang, Yusheng Ma, Yanbing Wang, Ming Jin, Jianping Bin, Zhiyong Chen, Zhonghua Teng
OBJECTIVE: α-Klotho is a potential biological marker of aging with satisfactory clinical applicability. However, its prognostic significance in age-related diseases has largely been undermined. Therefore, we aimed to report the prognostic value of serum α-klotho levels in age-related diseases. METHODS: Participants with available serum α-klotho data from the National Health and Nutrition Examination Survey (2007-2016) were included. Their survival status was collected at 7...
June 2024: Preventive Medicine Reports
https://read.qxmd.com/read/38689681/impact-of-cardiorespiratory-fitness-and-diabetes-status-on-cardiovascular-disease-and-all-cause-mortality-an-nhanes-retrospective-cohort-study
#55
JOURNAL ARTICLE
Gwendolyn A Ung, Kevin H Nguyen, Alvin Hui, Nathan D Wong, Elizabeth H Dineen
UNLABELLED: High cardiorespiratory fitness (CRF) is associated with decreased mortality in people with pre-diabetes (pre-DM) and diabetes mellitus (DM); however, the degree to which CRF attenuates the risk of cardiovascular disease (CVD)-related and all-cause mortality is unclear. STUDY OBJECTIVE: We examined the impact of CRF status on CVD-related morbidity and all-cause mortality in non-DM, Pre-DM, and DM populations. DESIGN AND SETTING: 13,968 adults from the Third US National Health and Nutrition Examination Survey (NHANES III) were stratified into non-DM, pre-DM, or DM groups based on HbA1c levels...
June 2024: American heart journal plus: cardiology research and practice
https://read.qxmd.com/read/38689632/elevated-cardiovascular-risk-and-acute-events-in-hospitalized-colon-cancer-survivors-a-decade-apart-study-of-two-nationwide-cohorts
#56
JOURNAL ARTICLE
Rupak Desai, Avilash Mondal, Vivek Patel, Sandeep Singh, Shaylika Chauhan, Akhil Jain
BACKGROUND: Over the years, strides in colon cancer detection and treatment have boosted survival rates; yet, post-colon cancer survival entails cardiovascular disease (CVD) risks. Research on CVD risks and acute cardiovascular events in colorectal cancer survivors has been limited. AIM: To compare the CVD risk and adverse cardiovascular outcomes in current colon cancer survivors compared to a decade ago. METHODS: We analyzed 2007 and 2017 hospitalization data from the National Inpatient Sample, studying two colon cancer survivor groups for CVD risk factors, mortality rates, and major adverse events like pulmonary embolism, arrhythmia, cardiac arrest, and stroke, adjusting for confounders via multivariable regression analysis...
April 24, 2024: World Journal of Clinical Oncology
https://read.qxmd.com/read/38689456/event-related-potential-changes-following-12-week-yoga-practice-in-t2dm-patients-a-randomized-controlled-trial
#57
JOURNAL ARTICLE
Amit Kanthi, Singh Deepeshwar, Kaligal Chidananda, Mahadevappa Vidyashree, Dwivedi Krishna
Introduction. Type 2 diabetes patients are more likely to experience cognitive decline (1.5%) and dementia (1.6%) than healthy individuals. Although cognitive impairment adversely affects Type 2 diabetes mellitus (T2DM) patients, it is the least addressed complication of T2DM patients. Objective. The present study attempts to examine the changes in cognitive performance of T2DM patients and the probable factors contributing to the changes following 12-week yoga practice. Methods. The current study is a parallel group randomized controlled trial that compared the outcomes of the participants randomized to a yoga group (YG) ( n  = 25) and to a wait-list control group ( n  = 29)...
April 30, 2024: Clinical EEG and Neuroscience: Official Journal of the EEG and Clinical Neuroscience Society (ENCS)
https://read.qxmd.com/read/38689163/sirt6-in-regulation-of-mitochondrial-damage-and-associated-cardiac-dysfunctions-a-possible-therapeutic-target-for-cvds
#58
REVIEW
K P Divya, Navjot Kanwar, P V Anuranjana, Gautam Kumar, Fathima Beegum, Krupa Thankam George, Nitesh Kumar, K Nandakumar, Abhinav Kanwal
Cardiovascular diseases (CVDs) can be described as a global health emergency imploring possible prevention strategies. Although the pathogenesis of CVDs has been extensively studied, the role of mitochondrial dysfunction in CVD development has yet to be investigated. Diabetic cardiomyopathy, ischemic-reperfusion injury, and heart failure are some of the CVDs resulting from mitochondrial dysfunction Recent evidence from the research states that any dysfunction of mitochondria has an impact on metabolic alteration, eventually causes the death of a healthy cell and therefore, progressively directing to the predisposition of disease...
April 30, 2024: Cardiovascular Toxicology
https://read.qxmd.com/read/38688836/reduced-immunogenicity-of-covid-19-vaccine-in-obese-patients-with-type-2-diabetes-a-cross-sectional-study
#59
JOURNAL ARTICLE
Hiroko Takahashi, Jun Eguchi, Mayu Watanabe, Masanori Nakayama, Jun Wada
The global pandemic of coronavirus infection 2019 (COVID-19) was an unprecedented public health emergency. Several clinical studies reported that heart disease, lung disease, diabetes, hypertension, dyslipidemia, and obesity are critical risk factors for increased severity of and hospitalization for COVID-19. This is largely because patients with these underlying medical conditions can show poor immune responses to the COVID-19 vaccinations. Diabetes is one of the underlying conditions most highly associated with COVID-19 susceptibility and is considered a predictor of poor prognosis of COVID-19...
April 2024: Acta Medica Okayama
https://read.qxmd.com/read/38688397/a-structure-based-pharmacophore-modelling-approach-to-identify-and-design-new-neprilysin-nep-inhibitors-an-in-silico-based-investigation
#60
JOURNAL ARTICLE
Shikha Thakur, Apurba Sinhari, Anil Bhanudas Gaikwad, Hemant R Jadhav
Neutral endopeptidase or neprilysin (NEP) cleaves the natriuretic peptides, bradykinin, endothelin, angiotensin II, amyloid β protein, substance P, etc., thus modulating their effects on heart, kidney, and other organs. NEP has a proven role in hypertension, heart disease, renal disease, Alzheimer's, diabetes, and some cancers. NEP inhibitor development has been in focus since the US FDA approved a combination therapy of angiotensin II type 1 receptor inhibitor (valsartan) and NEP inhibitor (sacubitril) for use in heart failure...
April 28, 2024: Archives of Biochemistry and Biophysics
keyword
keyword
96159
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.